CTA
AMGN icon

Clear Trail Advisors’s Amgen AMGN Stock Holding History

Clear Trail Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.53M Buy
9,755
+216
+2% +$73.9K 0.54% 53
2026
Q1 		$3.36M Buy
9,539
+1,480
+18% +$528K 0.56% 50
2025
Q4 		$2.64M Buy
+8,059
New +$2.56M 0.61% 42

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Clear Trail Advisors's AMGN Position: Q2 2026 in Review

Clear Trail Advisors increased its Amgen (AMGN) stake by 2.3% in Q2 2026, buying an estimated $73.9K and bringing the position to 9,755 shares worth $3.53M. The position accounts for 0.54% of the portfolio, ranked #53.

Clear Trail Advisors first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,134 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Clear Trail Advisors held 9,755 shares of Amgen worth $3.53M as of Q2 2026.
  • Clear Trail Advisors bought 216 Amgen shares in Q2 2026, an estimated $73.9K.
  • Amgen made up 0.54% of Clear Trail Advisors's portfolio in Q2 2026, its #53 holding.
  • Clear Trail Advisors first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • 3,134 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Clear Trail Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.